Format

Send to

Choose Destination
Eur J Clin Microbiol Infect Dis. 2019 Jun;38(6):1015-1022. doi: 10.1007/s10096-019-03492-4. Epub 2019 Feb 2.

The successful uptake and sustainability of rapid infectious disease and antimicrobial resistance point-of-care testing requires a complex 'mix-and-match' implementation package.

Author information

1
Na-908, Department of Medical Microbiology & Infectious Diseases, Erasmus University Medical Centre (Erasmus MC), Postbus 2040, 3000 CA, Rotterdam, Netherlands. j.hays@erasmusmc.nl.
2
Hahn-Schickard, Georges-Koehler-Allee 103, 79110, Freiburg, Germany.
3
Usher Institute of Population Health Sciences & Informatics, The University of Edinburgh, 9 Little France Road, Edinburgh, EH16 4UX, UK.
4
BioMérieux Data Analytics Unit, 3 Route de Port Michaud, 38390, La Balme Les Grottes, France.
5
University Hospital Münster, DGHM, Münster, Germany.
6
Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
7
Infection Control Program, WHO Collaborating Center for Patient Safety, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
8
F2G Ltd., Eccles, Manchester, UK.
9
University of Tromsø, Tromsø, Norway.
10
Robert Koch Institute, Wernigerode Branch, Wernigerode, Germany.
11
EUPHA (European Public Health Association), Otterstraat 118-124, Postbox 1568, 3500 BN, Utrecht, The Netherlands.
12
GVM Care and Research, (Presidio San Pier Damiano- Faenza-), Corso Garibaldi 11, 48022, Lugo, Ravenna, Italy.
13
Curetis GmbH, Holzgerlingen, Germany.
14
University of Manchester, Manchester, UK.
15
Dept. of Health Policy and Management, School of Public Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
16
The ESCMID Study Group for Genomic and Molecular Diagnostics (ESGMD), Basel, Switzerland.
17
Division of Infection and Pathway Medicine, Edinburgh Medical School: Biomedical Sciences, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh, EH16 4SB, UK.

Abstract

The emergence and spread of antimicrobial resistance is one of the major global issues currently threatening the health and wealth of nations, with effective guidelines and intervention strategies urgently required. Such guidelines and interventions should ideally be targeted at individuals, communities, and nations, requiring international coordination for maximum effect. In this respect, the European Joint Programming Initiative on Antimicrobial Resistance Transnational Working Group 'Antimicrobial Resistance - Rapid Diagnostic Tests' (JPIAMR AMR-RDT) is proposing to consider a 'mix-and-match' package for the implementation of point-of-care testing (PoCT), which is described in this publication. The working group was established with the remit of identifying barriers and solutions to the development and implementation of rapid infectious disease PoCT for combatting the global spread of antimicrobial resistance. It constitutes a multi-sectoral collaboration between medical, technological, and industrial opinion leaders involved in in vitro diagnostics development, medical microbiology, and clinical infectious diseases. The mix-and-match implementation package is designed to encourage the implementation of rapid infectious disease and antimicrobial resistance PoCT in transnational medical environments for use in the fight against increasing antimicrobial resistance.

KEYWORDS:

Diagnostic innovator; Future proofing; General public; Healthcare providers; Implementation package; Infectious diseases antimicrobial resistance; Point-of-care testing

PMID:
30710202
PMCID:
PMC6520316
DOI:
10.1007/s10096-019-03492-4
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center